GENETIC PROBING OF RESIDUES INVOLVED IN EBOLAVIRUS GLYCOPROTEIN ENTRY07/01/2018 - 06/30/2020 (PI)
NIH/National Institute of Allergy & Infectious Diseases1R21AI135517-01
ROLE FOR POLYAMINES IN EBOLA VIRUS REPLICATION02/01/2016 - 01/31/2019 (PI)
NIH/National Institute of Allergy & Infectious Diseases5R21AI121933-02
ASSESSMENT OF INFECTION ROUTE AND VULNERABILITY OF NEURAL PRECURSOR CLASSES TO ZIKA VIRUS09/30/2016 - 08/31/2018 (Co-PI)
PI:
Tarik Haydar, PhDNIH/National Institute of Neurological Disorders & Stroke5R21NS101151-02
DEVELOPMENT OF NEAR REAL-TIME, MULTIPLEXED DIAGNOSTICS FOR VIRAL HEMORRHAGIC FEVER08/01/2011 - 07/31/2018 (PI)
NIH/National Institute of Allergy & Infectious Diseases5R01AI096159-05
ELIMINATION OF PATHOGENIC IGE IN CYSTIC FRIBROSIS08/01/2016 - 05/01/2018 (PI)
The Brigham and Women's Hospital, Inc. NIH NHLBI5U54HL119145-05
INCLUSIVITY AND EXCLUSIVITY TESTING OF ADVANCED ASSAYS FOR FEVER OF UNKNOWN ORIGIN04/13/2017 - 04/12/2018 (PI)
Becton, Dickinson and Company DOD Naval Res Lab
POINT-OF-CARE NANOTECHNOLOGY DIAGNOSTIC FOR DIFFERENTIAL FEVER DIAGNOSIS10/01/2015 - 10/31/2017 (PI)
Becton, Dickinson and Company Paul G. Allen Fdn
BIOMARKER DISCOVERY03/10/2015 - 02/28/2017 (PI)
Johns Hopkins University Applied Physics Laboratory LLC, The Ntl Intel - IARPA
I/UCRC COLLABORATIVE RESEARCH07/01/2011 - 02/28/2017 (SP Co-PI of Sub-Project / SP)
I/UCRC: Industry Memberships
EVALUATION OF THE MECHANISM OF ACTION OF FDA-APPROVED COMPOUNDS THAT SHOW ACTIVITY AGAINST EBOLAVIRUS08/18/2014 - 02/17/2017 (PI)
Department of Defense/Army Medical Research Acquisition Activity
Showing 10 of 17 results.
Show All Results
ELIMINATION OF PATHOGENIC IGE IN CYSTIC FRIBROSIS02/01/2016 - 10/31/2016 (PI)
The Brigham and Women's Hospital, Inc. NIH NHLBI4U54HL119145-04
COMBINED VIRAL LOAD AND SEROLOGY PANEL FOR RAPID POC EBOLA DIAGNOSTICS03/01/2015 - 02/29/2016 (PI)
Nexgen Arrays LLC NIH NIAID1R43AI1185254-01
STAGE-SPECIFIC INHIBITORS OF ORTHOPOXVIRUSES04/15/2011 - 03/31/2014 (PI)
NIH/National Institute of Mental Health5R03MH094169-02
DEVELOPMENT AND CHARACTERIZATION OF ANIMAL MODELS FOR FILOVIRUSES02/15/2010 - 12/31/2013 (PI)
Department of Defense/Army
MICROARRAY PROCESSING AND ANALYSIS OF BIOLOGICAL SAMPLES FROM NON-HUMAN PRIMATE MODELS OF VIRAL INFECTIONS AND HUMAN CLINICAL SAMPLES SUPPORTING USAMRID GRANT: IDENTIFICATION OF BIOMARKERS12/30/2010 - 12/29/2012 (PI)
Harvard University DOD ARL
Control of the eIF4F Complex by Vesicular Stomatitis Virus08/01/2006 - 07/31/2009 (PI)
NIH/National Institute of Allergy & Infectious Diseases5 K22 AI64606 02
Proof of Concept Studies on a Class of Broad Spectrum Antiviral Components03/01/2008 - 02/28/2009 (PI)
Harvard University NIH NIAID